HPV-DeepSeek, an ultrasensitive blood test that detects circulating tumor HPV DNA, predicts head and neck cancer recurrence up to 17 months earlier than standard clinical methods, and could guide adjuvant treatment for these patients. The post Ultrasensitive HPV DNA Blood Test Could Help Personalize Head and Neck Cancer Treatment appeared first on Inside Precision Medicine .